These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. P2Y Sophocleous RA; Miles NA; Ooi L; Sluyter R Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202978 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods. Balázs B; Dankó T; Kovács G; Köles L; Hediger MA; Zsembery A Cell Physiol Biochem; 2013; 32(1):11-24. PubMed ID: 23867750 [TBL] [Abstract][Full Text] [Related]
9. Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors. Bidula S; Nadzirin IB; Cominetti M; Hickey H; Cullum SA; Searcey M; Schmid R; Fountain SJ Mol Pharmacol; 2022 Jan; 101(1):33-44. PubMed ID: 34718224 [TBL] [Abstract][Full Text] [Related]
10. Dissection of P2X4 and P2X7 Receptor Current Components in BV-2 Microglia. Trang M; Schmalzing G; Müller CE; Markwardt F Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187309 [TBL] [Abstract][Full Text] [Related]
12. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating. Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201 [TBL] [Abstract][Full Text] [Related]
13. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes. Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577 [TBL] [Abstract][Full Text] [Related]
14. Effects of dexamethasone on purinergic signaling in murine mast cells: Selective suppression of P2X7 receptor expression. Yoshida K; Ito M; Hoshino Y; Matsuoka I Biochem Biophys Res Commun; 2017 Dec; 493(4):1587-1593. PubMed ID: 28988113 [TBL] [Abstract][Full Text] [Related]
15. Structural and Functional Features of the P2X4 Receptor: An Immunological Perspective. Kanellopoulos JM; Almeida-da-Silva CLC; Rüütel Boudinot S; Ojcius DM Front Immunol; 2021; 12():645834. PubMed ID: 33897694 [TBL] [Abstract][Full Text] [Related]
16. Purinergic P2X receptors: structural models and analysis of ligand-target interaction. Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R Eur J Med Chem; 2015 Jan; 89():561-80. PubMed ID: 25462266 [TBL] [Abstract][Full Text] [Related]
17. Podocyte Purinergic P2X4 Channels Are Mechanotransducers That Mediate Cytoskeletal Disorganization. Forst AL; Olteanu VS; Mollet G; Wlodkowski T; Schaefer F; Dietrich A; Reiser J; Gudermann T; Mederos y Schnitzler M; Storch U J Am Soc Nephrol; 2016 Mar; 27(3):848-62. PubMed ID: 26160898 [TBL] [Abstract][Full Text] [Related]
18. Improvement of the affinity of an anti-rat P2X4 receptor antibody by introducing electrostatic interactions. Shinozaki C; Kohno K; Shiroishi M; Takahashi D; Yoshikawa Y; Abe Y; Hamase K; Nakakido M; Tsumoto K; Inoue K; Tsuda M; Ueda T Sci Rep; 2022 Jan; 12(1):131. PubMed ID: 34996944 [TBL] [Abstract][Full Text] [Related]
19. Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4. Paalme V; Rump A; Mädo K; Teras M; Truumees B; Aitai H; Ratas K; Bourge M; Chiang CS; Ghalali A; Tordjmann T; Teras J; Boudinot P; Kanellopoulos JM; Rüütel Boudinot S Front Immunol; 2019; 10():2074. PubMed ID: 31552031 [TBL] [Abstract][Full Text] [Related]
20. Discovery and Characterization of the Potent and Selective P2X4 Inhibitor Werner S; Mesch S; Hillig RC; Ter Laak A; Klint J; Neagoe I; Laux-Biehlmann A; Dahllöf H; Bräuer N; Puetter V; Nubbemeyer R; Schulz S; Bairlein M; Zollner TM; Steinmeyer A J Med Chem; 2019 Dec; 62(24):11194-11217. PubMed ID: 31746599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]